Literature DB >> 22562363

Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency.

Gustaf Christoffersson1, Guangxiang Zang, Zhen W Zhuang, Evelina Vågesjö, Michael Simons, Mia Phillipson, Michael Welsh.   

Abstract

Vascular endothelial growth factor (VEGF)-A regulates angiogenesis, vascular morphology and permeability by signaling through its receptor VEGFR-2. The Shb adapter protein has previously been found to relay certain VEGFR-2 dependent signals and consequently vascular physiology and structure was assessed in Shb knockout mice. X-ray computed tomography of vessels larger than 24 μm diameter (micro-CT) after contrast injection revealed an increased frequency of 48-96 μm arterioles in the hindlimb calf muscle in Shb knockout mice. Intravital microscopy of the cremaster muscle demonstrated a less regular vasculature with fewer branch points and increased vessel tortuosity, changes that led to an increased blood flow velocity. Reduced in vivo angiogenesis was observed in Shb knockout Matrigel™ plugs. Unlike the wild-type situation, VEGF-A did not provoke a dissociation of VE-cadherin from adherens junctions in Shb knockout venules. The reduced angiogenesis and altered properties of junctions had consequences for two patho-physiological responses to arterial occlusion: vascular permeability was reduced in the Shb knockout cremaster muscle after ligation of one supplying artery and heat-induced blood flow determined by Laser-Doppler measurements was decreased in the hindlimb after ligation of the femoral artery. Consequently, the Shb knockout mouse exhibited structural and functional (angiogenesis and vascular permeability) vascular abnormalities that have implications for understanding the function of VEGF-A under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562363      PMCID: PMC4059510          DOI: 10.1007/s10456-012-9275-z

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  37 in total

1.  Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability.

Authors:  B P Eliceiri; R Paul; P L Schwartzberg; J D Hood; J Leng; D A Cheresh
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

2.  Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo.

Authors:  Sulochana S Bhandarkar; Jacqueline Bromberg; Carol Carrillo; Ponniah Selvakumar; Rajendra K Sharma; Betsy N Perry; Baskaran Govindarajan; Levi Fried; Allie Sohn; Kalpana Reddy; Jack L Arbiser
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

Review 3.  Local control of skeletal muscle blood flow during exercise: influence of available oxygen.

Authors:  Darren P Casey; Michael J Joyner
Journal:  J Appl Physiol (1985)       Date:  2011-09-01

4.  Endothelial gaps: time course of formation and closure in inflamed venules of rats.

Authors:  P Baluk; A Hirata; G Thurston; T Fujiwara; C R Neal; C C Michel; D M McDonald
Journal:  Am J Physiol       Date:  1997-01

5.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

6.  HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.

Authors:  Charlotte Rolny; Massimiliano Mazzone; Sònia Tugues; Damya Laoui; Irja Johansson; Cathy Coulon; Mario Leonardo Squadrito; Inmaculada Segura; Xiujuan Li; Ellen Knevels; Sandra Costa; Stefan Vinckier; Tom Dresselaer; Peter Åkerud; Maria De Mol; Henriikka Salomäki; Mia Phillipson; Sabine Wyns; Erik Larsson; Ian Buysschaert; Johan Botling; Uwe Himmelreich; Jo A Van Ginderachter; Michele De Palma; Mieke Dewerchin; Lena Claesson-Welsh; Peter Carmeliet
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

7.  Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules.

Authors:  Fabienne Baffert; Tom Le; Gavin Thurston; Donald M McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-08-26       Impact factor: 4.733

Review 8.  Arterial-venous specification during development.

Authors:  Matthew R Swift; Brant M Weinstein
Journal:  Circ Res       Date:  2009-03-13       Impact factor: 17.367

9.  The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration.

Authors:  Kristina Holmqvist; Michael J Cross; Charlotte Rolny; Robert Hägerkvist; Nader Rahimi; Taro Matsumoto; Lena Claesson-Welsh; Michael Welsh
Journal:  J Biol Chem       Date:  2004-03-16       Impact factor: 5.157

Review 10.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

View more
  8 in total

1.  Absence of the adaptor protein Shb potentiates the T helper type 2 response in a mouse model of atopic dermatitis.

Authors:  Karin Gustafsson; Elsa Willebrand; Michael Welsh
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

2.  Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts.

Authors:  Guangxiang Zang; Karin Gustafsson; Maria Jamalpour; JongWook Hong; Guillem Genové; Michael Welsh
Journal:  BMC Cancer       Date:  2015-04-08       Impact factor: 4.430

3.  Hydrogen sulfide metabolism regulates endothelial solute barrier function.

Authors:  Shuai Yuan; Sibile Pardue; Xinggui Shen; J Steven Alexander; A Wayne Orr; Christopher G Kevil
Journal:  Redox Biol       Date:  2016-08-11       Impact factor: 11.799

4.  Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas.

Authors:  Xiujuan Li; Kailash Singh; Zhengkang Luo; Mariela Mejia-Cordova; Maria Jamalpour; Björn Lindahl; Ganlin Zhang; Stellan Sandler; Michael Welsh
Journal:  Oncotarget       Date:  2018-04-10

5.  The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors.

Authors:  Qi He; Xiujuan Li; Kailash Singh; Zhengkang Luo; Mariela Meija-Cordova; Maria Jamalpour; Björn Lindahl; Vitezslav Kriz; Reetta Vuolteenaho; Maria Ulvmar; Michael Welsh
Journal:  Sci Rep       Date:  2019-05-17       Impact factor: 4.379

6.  Temporal Dynamics of VEGFA-Induced VEGFR2/FAK Co-Localization Depend on SHB.

Authors:  Ilkka Pietilä; Djenolan Van Mourik; Andreas Tamelander; Vitezslav Kriz; Lena Claesson-Welsh; Anders Tengholm; Michael Welsh
Journal:  Cells       Date:  2019-12-15       Impact factor: 6.600

7.  Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in Shb-Deficient Endothelial Cells Increases Tumor Lung Metastasis.

Authors:  Qi He; Maria Jamalpour; Eric Bergquist; Robin L Anderson; Karin Gustafsson; Michael Welsh
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

Review 8.  Perspectives on Vascular Regulation of Mechanisms Controlling Selective Immune Cell Function in the Tumor Immune Response.

Authors:  Michael Welsh
Journal:  Int J Mol Sci       Date:  2022-02-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.